HI HB673 | 2015 | Regular Session

Status

Spectrum: Partisan Bill (Democrat 7-0)
Status: Introduced on January 26 2015 - 25% progression, died in chamber
Action: 2015-02-10 - The committee(s) on HLT recommend(s) that the measure be deferred.
Text: Latest bill text (Introduced) [HTML]

Summary

Requires insurance coverage for embryo, oocyte, and sperm cryopreservation procedures to preserve the fertility of adults diagnosed with cancer who have not yet started cancer treatment.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Embryo, Oocyte, and Sperm Cryopreservation; Insurance

Sponsors


History

DateChamberAction
2015-02-10HouseThe committee(s) on HLT recommend(s) that the measure be deferred.
2015-02-06HouseBill scheduled for decision making on Tuesday, 02-10-15 8:45AM in conference room 329.
2015-02-06HouseThe committee(s) on HLT recommend(s) that the measure be deferred until 02-10-15 at 8:45 am.
2015-02-04HouseBill scheduled for decision making on Friday, 02-06-15 11:30AM in House conference room 329.
2015-02-04HouseThe committee(s) on HLT recommend(s) that the measure be deferred until 02-06-15 at 11:30 AM.
2015-02-02HouseBill scheduled to be heard by HLT on Wednesday, 02-04-15 9:00AM in House conference room 329.
2015-01-28HouseReferred to HLT, CPC, FIN, referral sheet 2
2015-01-26HouseIntroduced and Pass First Reading.
2015-01-23HousePending introduction.

Same As/Similar To

SB781 (Same As) 2015-02-06 - The committee on HTH deferred the measure.

Hawaii State Sources


Bill Comments

feedback